Lutathera and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Lutathera (lutetium dotatate lu-177), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Sandostatin, and have Hypothyroidism.

The phase IV clinical study analyzes which people have Fainting when taking Lutathera. It is created by eHealthMe based on reports of 4,175 people who have side effects when taking Lutathera from the FDA, and is updated regularly.

What is Lutathera?

Lutathera has active ingredients of lutetium dotatate lu-177. eHealthMe is studying from 4,176 Lutathera users. Check the latest studies of Lutathera.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,458 drugs and 3,547 conditions by eHealthMe. Check the latest studies of Fainting.

On Jul, 19, 2026

4,175 people reported to have side effects when taking Lutathera.
Among them, 16 people (0.38%) have Fainting.

Among these 16 people:

How long have people been on Lutathera when they have Fainting? *

What is the gender of people who have Fainting when taking Lutathera? *

female: 25 %
male: 75 %

What is the age of people who have Fainting when taking Lutathera? *

What are other drugs people take besides Lutathera? *

What are other side effects people have besides Fainting? *

Nausea And Vomiting: 5 people, 31.25%
Abdominal Pain: 4 people, 25.00%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 4 people, 25.00%
Nausea (feeling of having an urge to vomit): 4 people, 25.00%
Intestinal Obstruction: 4 people, 25.00%
Dehydration (dryness resulting from the removal of water): 3 people, 18.75%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 12.50%
Constipation: 2 people, 12.50%
Fatigue (feeling of tiredness): 2 people, 12.50%
Fever: 2 people, 12.50%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 25.00%
Thyroid Cancer: 3 people, 18.75%
Neuroendocrine Tumor: 3 people, 18.75%
Carcinoid Tumor: 3 people, 18.75%
Unilateral Hydronephrosis (kidney stone that causes obstruction of the ureter): 2 people, 12.50%
Abdominal Pain: 2 people, 12.50%
Anal Fissure: 2 people, 12.50%
Diabetes: 2 people, 12.50%
Flatulence (flatus expelled through the anus): 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Lutathera and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lutathera:

Lutathera (4,176 reports)

Fainting treatments and more:

Fainting (131,321 reports)

Browse all side effects of Lutathera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,458 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lutetium dotatate lu-177 (the active ingredients of Lutathera) and Lutathera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.